Kinaxis Inc. (TSE:KXS - Get Free Report) Senior Officer Vasile Gelu Ticala sold 3,534 shares of the company's stock in a transaction dated Friday, June 13th. The stock was sold at an average price of C$201.00, for a total transaction of C$710,334.00. Following the transaction, the insider now owns 596 shares of the company's stock, valued at C$119,796. This represents a 85.57% decrease in their position.
Vasile Gelu Ticala also recently made the following trade(s):
- On Friday, June 13th, Vasile Gelu Ticala sold 2,000 shares of Kinaxis stock. The shares were sold at an average price of C$201.00, for a total transaction of C$402,000.00.
Kinaxis Stock Down 0.0%
TSE KXS traded down C$0.10 during trading hours on Monday, reaching C$200.53. 86,268 shares of the company's stock were exchanged, compared to its average volume of 86,399. The company has a market capitalization of C$4.03 billion, a price-to-earnings ratio of 199.02, a price-to-earnings-growth ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a one year low of C$132.93 and a one year high of C$202.91. The company's 50-day moving average is C$188.93 and its two-hundred day moving average is C$175.48. The company has a debt-to-equity ratio of 12.12, a quick ratio of 2.29 and a current ratio of 1.89.
Analyst Ratings Changes
KXS has been the subject of a number of analyst reports. CIBC reduced their price objective on shares of Kinaxis from C$175.00 to C$170.00 in a research note on Friday, February 28th. Atb Cap Markets cut shares of Kinaxis from a "strong-buy" rating to a "hold" rating in a research note on Thursday, May 8th. ATB Capital lowered shares of Kinaxis from an "outperform" rating to a "sector perform" rating and set a C$210.00 price target on the stock. in a research report on Friday, May 9th. BMO Capital Markets boosted their target price on shares of Kinaxis from C$190.00 to C$225.00 in a research report on Friday, May 9th. Finally, Royal Bank of Canada boosted their target price on shares of Kinaxis from C$210.00 to C$225.00 in a research note on Friday, May 9th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Kinaxis presently has a consensus rating of "Moderate Buy" and a consensus price target of C$205.00.
Read Our Latest Analysis on Kinaxis
About Kinaxis
(
Get Free Report)
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
